The forecast is based on the assumption that there will be no further restrictive measures due to the pandemic which affect the health care system.Ĭompetence in post-COVID and long COVID treatmentsĪccording to current estimates, about one in 10 corona-infected people develop Post COVID or Long COVID symptoms. Therefore, the Management Board assumes that the Group is able to generate sales at the previous year's level and that the Group operating result will range between EUR 0.0 mill. The occupancy curve over the 2021 financial year including October suggests that the utilisation of medical and therapeutic services will remain stable. Given the relatively good vaccination rates, MEDICLIN assumes that this trend will continue in the fourth quarter. Transfers from acute hospitals have been increasing since the middle of the year and the reluctance to take advantage of rehabilitation services is steadily decreasing. The occupancy rate amounted to 81.1 % in the third quarter of 2021 and was thus higher than in the previous quarters. (: EUR 100.4 mill.).Ĭonstant increase in clinic occupancy rates As of September 30, 2021, cash and cash equivalents amounted to EUR 112.5 mill. were made in the first nine months of 2021, compared to EUR 20.2 mill. Despite a decline in headcount, staff costs rose by EUR 2.7 mill. or 4.0 %, mainly driven by expenditure for protective measures and, of course, the rise in operating business compared to the prior-year period. The result was burdened by an increase in raw materials and consumables used of EUR 3.4 mill. less benefits under the protective shield. below the figure in the first nine months of 2020, although the Group received EUR 24.0 mill. The Group operating result of EUR 1.4 mill. Capacity utilization in the 9-month period of 2021 was 74.7%, one percentage point above the previous year's figure
or 5.1 % compared to the previous year's period. At operating level, without benefits under the protective shield, Group sales increased by EUR 23.3 mill.
from benefits under the protective shield to manage the coronavirus pandemic, down from EUR 37.7 mill. In the first nine months of 2021, MEDICLIN generated Group sales of EUR 498.1 mill. DGAP-News: MediClin AG / Key word(s): Quarter Results MediClin AG: Business development to date shows an increasing capacity utilization in the clinics / 13:15 The issuer is solely responsible for the content of this announcement.īusiness development to date shows an increasing capacity utilization in the clinics
0 kommentar(er)
